Oxcarbazepine

Expert Opinion on Pharmacotherapy

Volumn 3, Issue 1, 2002, Pages 59-71

  Beydoun, Ahmad ^a   Kutluay, Ekrem ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Bipolar disorders; Efficacy; Epilepsy; Mania; Neuropathic pain; Oxcarbazepine; Partial seizures; Pharmacokinetics; Safety; Tolerability; Trigeminal neuralgia

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CALCIUM ANTAGONIST; CARBAMAZEPINE; CHLORPROMAZINE; CIMETIDINE; CLOZAPINE; DEXTROPROPOXYPHENE; DIHYDROPYRIDINE DERIVATIVE; DIURETIC AGENT; DRUG METABOLITE; ERYTHROMYCIN; ETHINYLESTRADIOL; FLUOXETINE; HALOPERIDOL; LEVONORGESTREL; LITHIUM; MONOHYDROXY DERIVATIVE; NEFAZODONE; NONSTEROID ANTIINFLAMMATORY AGENT; OLANZAPINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENYTOIN; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL; WARFARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ATAXIA; CONTROLLED STUDY; DISTRIBUTION VOLUME; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CONJUGATION; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG TOLERABILITY; EPILEPSY; FATIGUE; HUMAN; HYPONATREMIA; MANIC DEPRESSIVE PSYCHOSIS; MOUSE; NAUSEA AND VOMITING; NONHUMAN; PERIPHERAL NEUROPATHY; RAT; REVIEW; SEIZURE; SOMNOLENCE; TRIGEMINUS NEURALGIA; VERTIGO;

ADULT; ANIMALS; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; COGNITION; EPILEPSY; HUMANS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; TRIGEMINAL NERVE DISEASES;

EID: 0036317763     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.3.1.59     Document Type: Review

References (67)

1. Oxcarbazepine
2. Oxcarbazepine: Mechanisms of action
3. Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures
4. Action of GP 47779, the active metabolite of oxcarbazepine on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission
5. Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents
6. ω-Conotoxin sensitivity and presynaptic inhibition of glutamergic sensory neurotransmission in vitro
7. Oxcarbazepine
8. Anticonvulsant action of oxcarbazepine, hydrocarbamazepine, and carbamazepine against metrazol-induced motor seizures in developing rats
9. Oxcarbazepine: A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia, and affective disorders
10. Clinical pharmacology and pharmacokinetics of oxcarbazepine
11. The clinical pharmaco-kinetics of the new antiepileptic drugs
12. 14C-oxcarbazepine in man
13. The distribution of 10-hydroxycarbazepine in blood compartments
14. Plasma level monitoring of oxcarbazepine in epileptic patients
15. Oxcarbazepine: Pharmacokinetic interactions and their clinical relevance
16. Rectal absorbtion of oxcarbazepine
17. Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects
18. Pharmacokinetics of oxcarbazepine and 10-hydroxycarbazepine in the new-born child of an oxcarbazepine-treated mother
19. Pharmacokinetics of oxcarbazepine in human placenta
20. The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites
21. Population pharmacokinetic analysis of oxcarbazepine (Trileptal®) in children with epilepsy
22. Oxcarbazepine does not interact with cimetidine in healthy volunteers
23. Absence of interaction between oxcarbazepine and erythromycin
24. Oxcarbazepine does not affect the anticoagulant activity of warfarin
25. Influence of single and repeated doses of oxcarbazepine on the pharmacokinetic profile of felodipine
26. Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women
27. Oxcarbazepine and oral contraceptives
28. Possible interaction between oxcarbazepine and an oral contraceptive
29. Serum sex hormone levels after replacing carbamazepine with oxcarbazepine
30. The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy
31. Clinically significant pharmacokinetic drug interactions between antiepileptic drugs
32. Oxcarbazepine for treatment of partial epilepsy: A review and recommendations for clinical use
33. Oxcarbazepine: Placebo-controlled, dose-ranging trial in refractory partial epilepsy
34. Adjunctive therapy with oxcarbazepine in children with partial seizures
35. Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures
36. Oxcarbazepine monotherapy for partial-onset seizures: A multicentre, double-blind, clinical trial
37. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures
38. Safety and efficacy of oxcarbazepine 1200 mg/day in patients with recent-onset partial epilepsy
39. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy
40. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy
41. A double-blind controlled clinical trial: Oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy
42. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy
43. Practical aspects of oxcarbazepine treatment
44. Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report
45. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update
46. Lithium-carbamazepine neurotoxicity and risk factors
47. Double-blind, within-patient study to evaluate the influence of viloxazine on the steady state plasma levels of oxcarbazepine and its metabolites
48. Clinical trial of carbamazepine (Tegretol) in trigeminal neurolgia
49. Carbamazepine in the treatment of neurolgia. Use and side effects
50. A four year double-blind study of tegretol in facial pain
51. Trigeminal neuralgia: Its treatment with two new carbamazepine analogues
52. Oxcarbazepine: A new drug in the management of intractable trigeminal neuralgia
53. The analgesic effect of carbamazepine in trigeminal neuralgia
54. Open-label trial of oxcarbazepine in neuropathic pain
55. Oxcarbazepine in treatment of painful peripheral neuropathies
56. Neuropathic pain and injured nerve: Peripheral mechanisms
57. Cross reactive skin eruption with both carbamazepine and oxcarbazepine
58. Oxcarbazepine-induced hyponatremia, a cross-sectional study
59. Hyponatraemia during oxcarbazepine therapy
60. Metabolic encephalopathy: Oxcarbazepine (Trileptal)-induced hyponatraemia
61. Hyponatremic coma under oxcarbazepine therapy
62. Comparison of oxcarbazepine and carbamazepine: A double-blind study
63. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: One year follow-up
64. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers
65. Effects of oxcarbazepine and carbamazepine on the central nervous system: Computerised analysis of saccadic and smooth-pursuit eye movements
66. Comparison of the effects of carbamazepine and oxcarbazepine on peripheral nerve conduction